In an in-depth conversation, OSP senior editor, Liza Laws, interviews Adrian Kizewski, associate director at IQVIA, to ...

Seqster and PatientsLikeMe have announced a strategic partnership to integrate real-time electronic health record (EHR) data ...

LabWare Inc. and Mettler Toledo have announced a game-changing collaboration aimed at transforming laboratory productivity ...

Dr Dawn Thompson has over 20 years of experience in building technology platforms that leverage genomics at scale to produce ...

Our collaboration with Beckman Coulter aims to democratize access to the pTau217 antibody, developing it into a highly ...

Global health technology company myTomorrows announced a new partnership on Tuesday (Aug 27) with Pancreatic Cancer Europe ...

Astellas Pharma Inc. has announced the initiation of its phase 3 pivotal study, Highlight 1, for fezolinetant, an ...

Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS ...

The European Commission has approved ARS Pharmaceuticals’ adrenaline nasal spray for the emergency treatment of severe ...

Dalgety, one of the UK's leading medical cannabis cultivators, has achieved a significant milestone by securing a Home Office licence to supply medical cannabis within the UK.

UCB, a global biopharmaceutical leader, has taken a significant step in refining its strategic focus by divesting its mature neurology and allergy portfolio in China.

Results from a phase 2 trial of the candidate schizophrenia drug, currently known as NBI-1117568, show that it met the ...